Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer

BackgroundImmunotherapy has emerged as a promising strategy for pancreatic cancer. Radiotherapy not only mediates direct tumor cell killing but also provides a source of tumor antigens for dendritic cells (DCs) uptake and presentation via the induction of immunogenic cell death (ICD). However, the l...

Повний опис

Збережено в:

Бібліографічні деталі
Автори:	Jingjing Chen, Qiaoli Wang, Junmeng Zhu, Xinyuan Bai, Haochen Tang, Xiang Kong, Lu Zou, Qinghua Zheng, Yingxin Wang, Yan Zhao, Baorui Liu, Fanyan Meng, Juan Du
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2026-06-01
Серія:	Frontiers in Immunology
Предмети:	hydrogel in situ tumor vaccine Lactococcus lactis pancreatic cancer radiotherapy
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1789212/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer

Схожі ресурси